Holdings of State of New Jersey Common Pension Fund D
1425 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 31.6 % of the equity sleeve
Sector breakdown
- Technology 24.6 %
- Financials 9.2 %
- Communication 8.0 %
- Consumer discretionary 7.6 %
- Health care 7.1 %
- Industrials 6.4 %
- Consumer staples 3.9 %
- Funds 3.0 %
- Energy 2.6 %
- Real estate 2.3 %
- Utilities 1.8 %
- Materials 1.3 %
- Unattributed 22.1 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 98.6 %
- IN 0.4 %
- BR 0.3 %
- MX 0.2 %
- CN 0.1 %
- ES 0.1 %
- IL 0.1 %
- KZ 0.1 %
- KR 0.0 %
- ID 0.0 %
- KY 0.0 %
- LU 0.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 1,397 | 24.6B $ | 98.62 % |
| 2 | IN | 3 | 109.2M $ | 0.44 % |
| 3 | BR | 4 | 82.2M $ | 0.33 % |
| 4 | MX | 5 | 42.5M $ | 0.17 % |
| 5 | CN | 2 | 26.1M $ | 0.10 % |
| 6 | ES | 1 | 23.9M $ | 0.10 % |
| 7 | IL | 1 | 15.8M $ | 0.06 % |
| 8 | KZ | 1 | 14.6M $ | 0.06 % |
| 9 | KR | 1 | 10.5M $ | 0.04 % |
| 10 | ID | 1 | 7.4M $ | 0.03 % |
| 11 | KY | 2 | 4.5M $ | 0.02 % |
| 12 | LU | 1 | 3.7M $ | 0.01 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1,401 | Annexon Inc | 40,753 | 225.8K $ | |
| 1,402 | Eldridge BBB-B CLO ETF | 8,407 | 225K $ | |
| 1,403 | Criteo SA | 11,712 | 210K $ | |
| 1,404 | Taysha Gene Therapies Inc | 46,807 | 209.2K $ | |
| 1,405 | Xencor Inc | 17,084 | 206K $ | |
| 1,406 | Kura Oncology Inc | 25,278 | 205.5K $ | |
| 1,407 | Compass Therapeutics Inc | 38,113 | 201.6K $ | |
| 1,408 | AtaiBeckley Inc | 56,493 | 200K $ | |
| 1,409 | Arvinas Inc | 18,657 | 197.8K $ | |
| 1,410 | Olema Pharmaceuticals Inc | 12,901 | 192.4K $ | |
| 1,411 | ORIC Pharmaceuticals Inc | 14,978 | 189.8K $ | |
| 1,412 | Janux Therapeutics Inc | 13,361 | 185.7K $ | |
| 1,413 | Phathom Pharmaceuticals Inc | 15,997 | 177.7K $ | |
| 1,414 | Monte Rosa Therapeutics Inc | 10,553 | 173.6K $ | |
| 1,415 | CorMedix Inc | 25,343 | 172.1K $ | |
| 1,416 | Sana Biotechnology Inc | 59,171 | 170.4K $ | |
| 1,417 | MiMedx Group Inc | 40,492 | 159.9K $ | |
| 1,418 | CytomX Therapeutics Inc | 31,848 | 149.7K $ | |
| 1,419 | ARS Pharmaceuticals Inc | 18,576 | 149.2K $ | |
| 1,420 | Cullinan Therapeutics Inc | 10,095 | 143.5K $ | |
| 1,421 | Myriad Genetics Inc | 31,856 | 143.4K $ | |
| 1,422 | Savara Inc | 23,627 | 129K $ | |
| 1,423 | Prime Medicine Inc | 30,845 | 107.3K $ | |
| 1,424 | Bicycle Therapeutics PLC | 20,105 | 93.3K $ | |
| 1,425 | Gamestop Corp | 14,693 | 56.7K $ |